In those cases of ESFTs which display focal positivity for S100 or desmin, additional immunohistochemical stains for melanoma markers (HMB45, Melan-A) and specific skeletal muscle markers (myogenin, myoD1) can be utilized to exclude melanoma and rhabdomyosarcoma. The gene discussed is MLANA; the disease is melanoma.